Two-year recall for people with no diabetic retinopathy: a multiethnic population-based retrospective cohort study using real-world data to quantify the effect

Background/Aims: The English Diabetic Eye Screening Programme (DESP) offers people living with diabetes (PLD) annual screening. Less frequent screening has been advocated among PLD without diabetic retinopathy (DR), but evidence for each ethnic group is limited. We examined the potential effect of biennial vs annual screening on the detection of sight-threatening diabetic retinopathy (STDR) and proliferative diabetic retinopathy (PDR) among PLD without DR from a large urban-multi-ethnic English DESP. Methods: PLD in North-East London DESP (Jan-2012 to Dec-2021) with no DR on two prior consecutive screening visits with up to eight years of follow-up were examined. Annual STDR and PDR incidence rates, overall, and by ethnicity were quantified. Delays in identification of STDR and PDR events had 2-year screening intervals been used were determined. Findings: Among 82,782 PLD (37% white, 36% South Asian, and 16% black people), there were 1,788 incident STDR cases over mean 4.3 (SD 2.4) years (STDR rate 0.51, 95%CI 0.47-0.55 per 100-person-years). STDR incidence rates per 100-person-years by ethnicity were 0.55 (95% CI 0.48-0.62) for South Asian, 0.34 (0.29-0.40) for white, and 0.77 (0.65-0.90) for black people. Biennial screening would have delayed diagnosis by 1-year for 56.3% (1,007/1,788) with STDR and 43.6% (45/103) with PDR. Standardised cumulative rates of delayed STDR per-100,000 for each ethnic group were 1904 (95%CI 1683-2154) for black, 1276 (1153-1412), and 844 (745-955) for white people. Interpretation: Biennial screening would have delayed detection of some STDR and PDR by one-year especially among those of black ethnic origin, leading to healthcare inequalities.

[1]  B. Duncan,et al.  IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.

[2]  A. Rudnicka,et al.  Effect of ethnicity and other sociodemographic factors on attendance at diabetic eye screening: a 12-month retrospective cohort study , 2021, BMJ Open.

[3]  James G. Lathe,et al.  Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT , 2020, Diabetologia.

[4]  Stephen J. Aldington,et al.  Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients , 2020, British Journal of Ophthalmology.

[5]  D. Owens,et al.  Cost-effectiveness of biennial screening for diabetes related retinopathy in people with type 1 and type 2 diabetes compared to annual screening , 2020, The European Journal of Health Economics.

[6]  Giri N. K. Rangan,et al.  Committee , 2019, 2019 International Conference on Radar, Antenna, Microwave, Electronics, and Telecommunications (ICRAMET).

[7]  L. Goff,et al.  Ethnicity and Type 2 diabetes in the UK , 2019, Diabetic medicine : a journal of the British Diabetic Association.

[8]  P. Scanlon The English National Screening Programme for diabetic retinopathy 2003–2016 , 2017, Acta Diabetologica.

[9]  K. Bhaskaran,et al.  Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004–2014 , 2017, BMJ Open.

[10]  A. Rudnicka,et al.  An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness. , 2016, Health technology assessment.

[11]  Catherine Egan,et al.  Automated Diabetic Retinopathy Image Assessment Software: Diagnostic Accuracy and Cost-Effectiveness Compared with Human Graders. , 2016, Ophthalmology.

[12]  Stephen J. Aldington,et al.  Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. , 2015, Health technology assessment.

[13]  S. Taylor-Phillips,et al.  Extending the diabetic retinopathy screening interval beyond 1 year: systematic review , 2015, British Journal of Ophthalmology.

[14]  M. Bachmann,et al.  Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals , 2014, Diabetes Care.

[15]  D. Owens,et al.  Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service , 2014, British Journal of Ophthalmology.

[16]  G. Roglić,et al.  Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[17]  Stephen J. Aldington,et al.  A Simple Risk Stratification for Time to Development of Sight-Threatening Diabetic Retinopathy , 2013, Diabetes Care.

[18]  S. Sivaprasad,et al.  Ethnic Variation in the Prevalence of Visual Impairment in People Attending Diabetic Retinopathy Screening in the United Kingdom (DRIVE UK) , 2012, PloS one.

[19]  R Greenwood,et al.  Grading and disease management in national screening for diabetic retinopathy in England and Wales , 2003, Diabetic medicine : a journal of the British Diabetic Association.